TelTex4BP: A mobile program to help adults with hypertension in Nepal
Official title: Effectiveness and Adoption of the Structured mHealth Intervention for Improving Blood Pressure Control (TelTex4BP) Among Adults With Hypertension in Nepal: A Randomized Controlled Trial
Run by Central Department of Public Health · NCT05979168 · Data updated 2026-11-12
A mobile text and phone-based program (TelTex4BP) helps adults with high blood pressure in Nepal take their medicines and adopt healthier habits to lower blood pressure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Central Department of Public Health Academic / other |
| Locations | 2 sites (Kathmandu, Bagmati and 1 other locations) |
| Status | Recruiting |
| Started | November 2, 2025 |
| Main results expected | December 15, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | July 8, 2026 |
| Trial ID | NCT05979168 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with hypertension on blood pressure–lowering meds for at least 3 months with uncontrolled BP who have access to a mobile phone and can read messages.
✕Probably not a fit
Patients without regular mobile phone access or who have severe comorbidities or cognitive impairment may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a hybrid effectiveness-implementation study that tests a 6-month mobile health intervention delivered via text messages and calls to improve blood pressure, medication adherence, and lifestyle habits among hypertensive adults in Nepal. It uses a parallel randomized controlled design with a qualitative component to understand how the program fits into local care, guided by the RE-AIM framework. The intervention is codesigned with patients, families, and healthcare providers and is evaluated for reach, adoption, fidelity, maintenance, and clinical outcomes at 6 and 12 months. The goal is to see if the approach can be scaled in similar LMIC settings if effective.
Why it matters
Potential benefit: If successful, the program could improve blood pressure control and reduce cardiovascular risk in Nepal and similar LMICs.
How similar studies have gone: Preliminary mobile health pilots in similar settings showed reductions in blood pressure, supporting potential benefit for larger trials.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of hypertension * Currently receiving/prescribed blood pressure-lowering medication for more than three months * With uncontrolled blood pressure (\>130/80mm of Hg) * Should have access to a mobile phone * Able to read text messages ( by themselves/with the help of family) Exclusion Criteria: * Diagnosed with myocardial infarction, stroke, and kidney failure * Severe mental illness, cognitive impairment * Pregnant women or in the postpartum period
Where it's running
-
Sahid Gangalal National Heart Center
Kathmandu, Bagmati, Nepal Recruiting -
Apara Innovations Pvt Ltd
Kathmandu, Pradesh 3 (Bagmati), Nepal Recruiting
Study contacts
- Principal investigator: Buna Bhandari Bhattarai, PhD — Indiana University
- Study coordinator: Buna Bhandari, PhD
- Email: buna.bhandari@gmail.com
- Phone: 8508156644
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Focused ultrasound treatment for high blood pressure
This study is testing a new ultrasound treatment that aims to lower blood pressure by targeting fat around the kidneys in people with high blood pressure.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
Research on health inequality and genetic disparity in cardiovascular diseases
This study is trying to understand how health differences and genetics affect heart diseases in people from various ethnic backgrounds in the UK to help improve treatments for everyone.
-
Registry on controlling blood pressure in ten thousand patients
This study is testing how well 24-hour blood pressure monitoring can help people with high blood pressure manage their condition and improve their heart health.
-
Rural Telemedicine-Enabled Care to Prevent Stroke in Older Adults in China
A telemedicine-supported care model led by rural doctors will be tested to see if it can reduce stroke and heart problems in adults 65+ living in rural China.
-
Home-based cardiovascular health screening for people turning 50, 55, 60, 65, 70 or 75 in Uppsala
This trial tests whether giving people a home blood pressure monitor, a dried blood spot kit, and a questionnaire can find more cardiovascular risk factors than usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.